-
This Drug Discovery Stock Rises 50% in 1 Year: What Is Driving a Loss Making Biotech?
- September 17, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
No Comments
One clinical stage central nervous system research company gained about 50% in twelve months while posting record losses. Here is what moved the price and what could go wrong.
-
Suven Life Sciences Share Price Target 2026: Stock Analysis, Share Price Today, Bull Case and Bear Case After Q1 FY27
- June 24, 2026
- Posted by: Kunal Singla
- Category: News
Suven Life Sciences share price target 2026: base case Rs 240 to Rs 312 against Rs 305.55 after Q1 FY27 loss widened to Rs 127.61 crore as R&D rose; Alzheimer’s Phase 3 is near full enrolment.